Kimberly Hammer

1.9k total citations
32 papers, 711 citations indexed

About

Kimberly Hammer is a scholar working on Surgery, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Kimberly Hammer has authored 32 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Kimberly Hammer's work include Natural Compound Pharmacology Studies (6 papers), Cholesterol and Lipid Metabolism (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Kimberly Hammer is often cited by papers focused on Natural Compound Pharmacology Studies (6 papers), Cholesterol and Lipid Metabolism (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Kimberly Hammer collaborates with scholars based in United States, China and Austria. Kimberly Hammer's co-authors include Diane F. Birt, Shaneabbas Raza, Othman Ghribi, Eve Syrkin Wurtele, Matthew L. Hillwig, Patricia A. Murphy, Milagros Zegarra, Avery Solco, Philip M. Dixon and Jared Schommer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Gut.

In The Last Decade

Kimberly Hammer

31 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly Hammer United States 17 246 166 139 126 89 32 711
Zhiguang Sun China 13 396 1.6× 133 0.8× 57 0.4× 78 0.6× 60 0.7× 37 799
Karen Regan United States 15 158 0.6× 77 0.5× 84 0.6× 121 1.0× 39 0.4× 48 1.0k
Yijie Wang China 18 289 1.2× 131 0.8× 102 0.7× 45 0.4× 40 0.4× 63 1.1k
Yijie Li China 19 297 1.2× 76 0.5× 58 0.4× 83 0.7× 67 0.8× 86 830
Lawrence Owusu China 16 466 1.9× 72 0.4× 69 0.5× 65 0.5× 74 0.8× 26 877
Marina Liso Italy 21 412 1.7× 103 0.6× 103 0.7× 77 0.6× 31 0.3× 42 1.2k
Bin Peng China 14 284 1.2× 59 0.4× 122 0.9× 74 0.6× 149 1.7× 43 1.0k
Tzu‐Chin Wu Taiwan 21 354 1.4× 54 0.3× 131 0.9× 77 0.6× 56 0.6× 50 1.1k

Countries citing papers authored by Kimberly Hammer

Since Specialization
Citations

This map shows the geographic impact of Kimberly Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Hammer more than expected).

Fields of papers citing papers by Kimberly Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Hammer. The network helps show where Kimberly Hammer may publish in the future.

Co-authorship network of co-authors of Kimberly Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Hammer. A scholar is included among the top collaborators of Kimberly Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Hammer. Kimberly Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammer, Kimberly, et al.. (2024). Cannabidiol (CBD) and hemp oil use in veterans using a VA Pain Clinic: a cross-sectional survey study. Journal of Addictive Diseases. 43(2). 190–193. 1 indexed citations
2.
Hammer, Kimberly, et al.. (2023). Does clinician-initiated Clostridioides difficile testing improve outcomes of patients with Clostridioides Difficile infection?. American Journal of Infection Control. 51(10). 1085–1088.
3.
Rhee, Yeong, Jeremy M. Hamm, Kimberly Hammer, et al.. (2023). The Prevalence and Trends of Instrumental Activities of Daily Living Impairments in the United States from 2008–2018. Journal of Alzheimer s Disease Reports. 7(1). 271–278. 7 indexed citations
4.
Hammer, Kimberly, et al.. (2022). Evaluation of adenosine triphosphate bioluminescence-based system in rooms occupied by patients with methicillin resistant Staphylococcus aureus. SHILAP Revista de lepidopterología. 1(3). 217–220. 1 indexed citations
5.
6.
Hammer, Kimberly, et al.. (2019). Longitudinal study on the detection of Clostridioides difficile at the Fargo Veteran Affairs Community Living Center. American Journal of Infection Control. 48(7). 843–845. 1 indexed citations
7.
Hammer, Kimberly, et al.. (2018). A systematic review and meta-analysis on the use of prophylactic topical antibiotics for the prevention of uncomplicated wound infections. Infection and Drug Resistance. Volume 11. 417–425. 12 indexed citations
8.
Raza, Shaneabbas, et al.. (2017). The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells. Cancer Cell International. 17(1). 52–52. 39 indexed citations
9.
Marwarha, Gurdeep, Shaneabbas Raza, Kimberly Hammer, & Othman Ghribi. (2017). 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer. Chemistry and Physics of Lipids. 207(Pt B). 108–126. 42 indexed citations
10.
Dietz, Jessica, et al.. (2016). Impact of eliminating reflex urine cultures on performed urine cultures and antibiotic use. American Journal of Infection Control. 44(12). 1750–1751. 10 indexed citations
11.
Raza, Shaneabbas, Joyce E. Ohm, Archana Dhasarathy, et al.. (2015). The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. Molecular and Cellular Biochemistry. 410(1-2). 187–195. 53 indexed citations
12.
Hammer, Kimberly, et al.. (2014). Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era. Expert Review of Anti-infective Therapy. 12(5). 549–554. 41 indexed citations
13.
Hammer, Kimberly & Diane F. Birt. (2013). Evidence for Contributions of Interactions of Constituents to the Anti-Inflammatory Activity ofHypericum Perforatum. Critical Reviews in Food Science and Nutrition. 54(6). 781–789. 28 indexed citations
14.
15.
LaLone, Carlie A., Kimberly Hammer, Lankun Wu, et al.. (2009). Endogenous Levels ofEchinaceaAlkylamides and Ketones Are Important Contributors to the Inhibition of Prostaglandin E2 and Nitric Oxide Production in Cultured Macrophages. Journal of Agricultural and Food Chemistry. 57(19). 8820–8830. 26 indexed citations
16.
Chen, Haw‐Wen, et al.. (2009). Effect of ultraviolet B radiation on activator protein 1 constituent proteins and modulation by dietary energy restriction in SKH‐1 mouse skin. Molecular Carcinogenesis. 48(9). 843–852. 10 indexed citations
17.
Birt, Diane F., Mark P. Widrlechner, Kimberly Hammer, et al.. (2009). Hypericumin infection: Identification of anti-viral and anti-inflammatory constituents. Pharmaceutical Biology. 47(8). 774–782. 69 indexed citations
18.
Hammer, Kimberly, Matthew L. Hillwig, Jeffrey D. Neighbors, et al.. (2008). Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction. Phytochemistry. 69(12). 2354–2362. 24 indexed citations
19.
Weisse, Chick, et al.. (2004). Use of percutaneous arterial embolization for treatment of intractable epistaxis in three dogs. Journal of the American Veterinary Medical Association. 224(8). 1307–1311. 13 indexed citations
20.
Hammer, Johann, Kimberly Hammer, & Kurt Kletter. (1998). Lipids infused into the jejunum accelerate small intestinal transit but delay ileocolonic transit of solids and liquids. Gut. 43(1). 111–116. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiguang Sun Breakdown of academic impact, for papers by Karen Regan Breakdown of academic impact, for papers by Yijie Wang Breakdown of academic impact, for papers by Yijie Li Breakdown of academic impact, for papers by Lawrence Owusu Breakdown of academic impact, for papers by Marina Liso Breakdown of academic impact, for papers by Bin Peng Breakdown of academic impact, for papers by Tzu‐Chin Wu
Rankless by CCL
2026